We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Lundbeck (LUN) Danish Krona 5

Sell:162.55 DKK Buy:162.65 DKK Change: 2.70 DKK (1.63%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:162.55 DKK
Buy:162.65 DKK
Change: 2.70 DKK (1.63%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:162.55 DKK
Buy:162.65 DKK
Change: 2.70 DKK (1.63%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia. Its product portfolio includes: Cipralex for the treatment of depression and anxiety disorders, Ebixa for the treatment of Alzheimer’s disease, Azilect for the treatment of Parkinson’s disease, Xenazine for the treatment of Huntington’s disease and Sabril for the treatment of epilepsy, among others. The Company operates through a number of subsidiaries, such as Lundbeck SAS, Lundbeck GmbH, SIA Lundbeck Latvia and Lundbeck LLC.

Contact details

Ottiliavej 9
+45 () 36301311

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
32.92 billion DKK
Shares in issue:
198.70 million
Copenhagen Stock Exchange
Danish Krone

Key personnel

  • Lars Rasmussen
    Independent Chairman of the Board
  • Deborah Dunsire
    President, Chief Executive Officer
  • Lene Skole-Soerensen
    Deputy Chairman of the Board
  • Anders Goetzsche
    Chief Financial Officer, Executive Vice President
  • Elise Hauge
    Executive Vice President, People & Communication
  • Lars Bang
    Executive Vice President, Product Development & Supply
  • Keld Flintholm Joergensen
    Executive Vice President, Corporate Strategy & Business Development
  • Johan Luthman
    Executive Vice President, Research & Development
  • Jacob Tolstrup
    Executive Vice President of Commercial Operations

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.